Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $165.80 million
- Book Value:
- Revenue TTM:
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Imara Inc had its IPO on 2020-03-12 under the ticker symbol IMRA.
The company operates in the Healthcare sector and Biotechnology industry. Imara Inc has a staff strength of 6 employees.
Shares of Imara Inc opened at $23 at the start of the last trading session i.e. 2023-03-23.
The stocks traded within a range of $19.24 - $23.5, and closed at $21.
This is a -78.71% slip from the previous day's closing price.
A total volume of 0 shares were traded at the close of the day’s session.
In the last one week, shares of Imara Inc have slipped by -23.12%.
Imara Inc's Key Ratios
Imara Inc has a market cap of $165.80 million, indicating a price to book ratio of 1.9686 and a price to sales ratio of 0.
In the last 12-months Imara Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-33659000. The EBITDA ratio measures Imara Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Imara Inc’s operating margin was 0% while its return on assets stood at -23.08% with a return of equity of 1.69%.
In Q4, Imara Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Imara Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $0.06 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Imara Inc’s profitability.
Imara Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -1.263. Its price to sales ratio in the trailing 12-months stood at 0.
Imara Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $91.96 million
- Total Liabilities
- $1.83 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Imara Inc ended 2023 with $91.96 million in total assets and $0 in total liabilities. Its intangible assets were valued at $91.96 million while shareholder equity stood at $90.13 million.
Imara Inc ended 2023 with $0 in deferred long-term liabilities, $1.83 million in other current liabilities, 27000.00 in common stock, $-146009000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $88.20 million and cash and short-term investments were $88.20 million. The company’s total short-term debt was $0 while long-term debt stood at $0.
Imara Inc’s total current assets stands at $89.64 million while long-term investments were $0 and short-term investments were $0.00. Its net receivables were $0 compared to accounts payable of $149000.00 and inventory worth $0.
In 2023, Imara Inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Imara Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Imara Inc stock is currently trading at $21 per share. It touched a 52-week high of $23.5 and a 52-week low of $23.5. Analysts tracking the stock have a 12-month average target price of $1.4.
Its 50-day moving average was $4.7 and 200-day moving average was $2.91 The short ratio stood at 2 indicating a short percent outstanding of 0%.
Around 1663.2% of the company’s stock are held by insiders while 8132.1% are held by institutions.
Frequently Asked Questions About Imara Inc
Similar Industry Stocks (Biotechnology)
IMARA Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapeutics to treat patients suffering from serious diseases. The company was incorporated in 2016 and is based in Brookline, Massachusetts.